Schizophrenia: all 3,539 studies
Page 35 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Clinical Trial of Integrated Treatment Versus Standard Treatment in First Episode PsychosisStatus unknownNCT00157313Not applicable
- A Study of Strategies to Improve Schizophrenia TreatmentCompletedNCT00156637Not applicable
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933)CompletedNCT00156117Phase 3
- Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)CompletedNCT00156104Phase 3
- Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784)CompletedNCT00156091Phase 3
- Mutation Screening and Translocation Detection of DISC1 Gene in SchizophreniaCompletedNCT00155818
- Mutation Screening and Translocation Detection of DISC1 Gene in SchizophreniaCompletedNCT00155701
- A Genetic Linkage Study of SchizophreniaCompletedNCT00155688
- A Positional Cloning Study on SchizophreniaCompletedNCT00155649
- A Study on Etiological Factors of SchizophreniaTerminatedNCT00155636
- A Psychopathological Study of Latent (Early) Schizophrenia: Clinical Pathology/Neuropsychological DysfunctionsCompletedNCT00155519
- Molecular Genetic Study of Schizophrenia: Parent-Offspring TriosCompletedNCT00155506
- A Study on Risk Mutations of Vulnerability Genes of SchizophreniaStatus unknownNCT00155207
- A Long Term Study of Clozapine in Patients With Treatment-resistant SchizophreniaCompletedNCT00154258Phase 2
- Psychiatric Day Hospital TreatmentCompletedNCT00153959Not applicable
- Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947)CompletedNCT00151424Phase 3
- A First In Human Study Of PF-00184562 In Healthy VolunteersCompletedNCT00150215Phase 1
- Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and PlaceboCompletedNCT00149292Phase 2
- Memantine for the Treatment of Cognitive Dysfunction and Negative Symptoms in Patients With Chronic SchizophreniaTerminatedNCT00148616Phase 3
- Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute SchizophreniaTerminatedNCT00148590Phase 3
- Energy Homeostasis Under Treatment With Atypical AntipsychoticsCompletedNCT00148564Phase 4
- The Efficacy of Escitalopram for Negative Symptoms in SchizophreniaCompletedNCT00148447Phase 3
- Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in SchizophreniaCompletedNCT00148083Phase 3
- Naltrexone Treatment of Alcohol Abuse in SchizophreniaCompletedNCT00145847Phase 4
- Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
- Mozart Relapse StudyCompletedNCT00143351Phase 3
- Bexarotene Treatment in SchizophreniaStatus unknownNCT00141947Phase 3
- To Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxCompletedNCT00141479Phase 2
- Creatine Treatment in Psychiatric DisordersCompletedNCT00140192Phase 3
- Treatment of Acute Schizophrenia With Vitamin TherapyCompletedNCT00140166Phase 4
- Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderCompletedNCT00139919Phase 2
- Twice Daily Titration Study of Bifeprunox in Subjects With SchizophreniaCompletedNCT00139906Phase 2
- Israel Multicenter D-Serine Study (IMSER) for the Treatment of SchizophreniaStatus unknownNCT00138775Phase 2
- Cognitive Remediation in Supported Employment at Human Service Center (HSC)Status unknownNCT00138021Not applicable
- Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy MotivationCompletedNCT00137189Not applicable
- Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderCompletedNCT00137020Phase 4
- IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)CompletedNCT00136994Phase 3
- Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2CompletedNCT00135772
- Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1CompletedNCT00124683Phase 2
- A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With SchizophreniaCompletedNCT00119756Phase 3
- Evaluating a Collaborative Care Model for the Treatment of Schizophrenia (EQUIP)CompletedNCT00119574Not applicable
- Ethyl-Eicosapentaenoic Acid and Tardive DyskinesiaCompletedNCT00114595Phase 4
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
- Schizophrenia and Genetic CounselingStatus unknownNCT00111202
- A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.CompletedNCT00111189Phase 3
- The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
- Generalization of Training in SchizophreniaCompletedNCT00108199Not applicable
- Psychiatric Advance Directives for Improved Mental Health CareCompletedNCT00105794Not applicable
- Trial Evaluating Paliperidone Extended-Release (ER) Tablets Versus Placebo on Sleep in Schizophrenia PatientsCompletedNCT00105326Phase 2
- Study Of Talnetant Versus Placebo And Risperidone In SchizophreniaCompletedNCT00103727Phase 2
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00103571Phase 4
- Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With SchizophreniaCompletedNCT00101634Phase 3
- Aripiprazole Oral Acceptability TrialCompletedNCT00101569Phase 3
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00100776Phase 4
- Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia PatientsCompletedNCT00097942Phase 2
- Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective DisorderCompletedNCT00095524Phase 3
- Pharmacokinetic Characterization of Intramuscular Olanzapine DepotCompletedNCT00094640Phase 1
- Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With SchizophreniaCompletedNCT00090324Phase 3
- Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00090012Phase 4
- A Combination of Two Currently Approved Drugs to Enhance the Treatment of SchizophreniaCompletedNCT00089869Phase 1/2
- Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With SchizophreniaCompletedNCT00088491Phase 3
- Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00088478Phase 3
- Investigate Risperidone for the Treatment of Schizophrenia in AdolescentsCompletedNCT00088075Phase 3
- Study of Olanzapine vs. Aripiprazole in the Treatment of SchizophreniaCompletedNCT00088049Phase 4
- Study Of An FDA-approved Drug As Additional Therapy In Patients With SchizophreniaCompletedNCT00086593Phase 3
- A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.CompletedNCT00086320Phase 3
- Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00085891Phase 3
- Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With SchizophreniaCompletedNCT00085748Phase 3
- Trial Evaluating Three Fixed Doses of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaCompletedNCT00083668Phase 3
- Timing of Voluntary Movement in Patients With SchizophreniaCompletedNCT00080548
- Study of Three Doses of Aripiprazole in Patients With Acute SchizophreniaCompletedNCT00080327Phase 4
- Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder in Individuals With Severe Mental IllnessCompletedNCT00078741Phase 2
- Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With SchizophreniaCompletedNCT00078039Phase 3
- A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.CompletedNCT00077727Phase 3
- Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With SchizophreniaCompletedNCT00077714Phase 3
- Safety and Efficacy of an Anti-Psychotic in Patients With SchizophreniaCompletedNCT00074477Phase 2
- Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With SchizophreniaCompletedNCT00073320Phase 3
- Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone in the Treatment of SchizophreniaCompletedNCT00073164Phase 2
- Clinical Study Of Schizophrenia in Both Men and WomenCompletedNCT00071747Phase 3
- Medication Adherence in Older People With PsychosisStatus unknownNCT00071604Not applicable
- Rehabilitative Training for Older People With SchizophreniaCompletedNCT00071591Phase 2
- Enhancing the Outcome of Skills Training for People With SchizophreniaCompletedNCT00069433Not applicable
- Treatment Response to Rehabilitation in Patients With SchizophreniaCompletedNCT00063336Not applicable
- Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of SchizophreniaCompletedNCT00063297Phase 2
- Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective DisorderCompletedNCT00061802Phase 4
- Imaging of Brain Receptors in Healthy Volunteers and in Patients With SchizophreniaCompletedNCT00061789Phase 2
- Effects of Modafinil on Brain Function in Patients With SchizophreniaCompletedNCT00057707Phase 1
- Improving Antipsychotic Adherence Among Patients With Serious Mental IllnessCompletedNCT00057135Not applicable
- Treating Thought Problems in Patients With SchizophreniaCompletedNCT00051740Not applicable
- Olanzapine Versus Placebo in the Treatment of Adolescents With SchizophreniaCompletedNCT00051298Phase 3
- Treatment of Schizophrenia Through Internet-Based PsychoeducationCompletedNCT00051233Phase 2
- Schizophrenia Study In AdultsCompletedNCT00049946Phase 2
- Screening for Childhood-Onset Psychotic DisordersTerminatedNCT00049738
- Treating Drug-Resistant Childhood SchizophreniaCompletedNCT00048828Phase 4
- Antidepressant Treatment in Older Adults With SchizophreniaCompletedNCT00047450Not applicable
- Nicotine Patch for Nicotine Dependence in Individuals With Schizophrenia or Schizoaffective Disorder - 1TerminatedNCT00046813Phase 4
- Online Family Support and Education for SchizophreniaCompletedNCT00046085Not applicable
- The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I DisorderCompletedNCT00044187Phase 4
- Family Intervention for Mental Illness and Substance AbuseCompletedNCT00043693Not applicable
- Transcranial Magnetic Stimulation (TMS) Treatment for Patients With Persistent Auditory HallucinationsCompletedNCT00042159Not applicable